ASH 2024: MPN Research Highlights with Dr. Angela Fleischman

Discover the latest breakthroughs in Myeloproliferative Neoplasm (MPN) research from ASH 2024 with insights from MPN expert Dr. Angela Fleischman. This year’s conference unveiled progress in understanding and treating MPNs, including Polycythemia Vera (PV), Myelofibrosis (MF), and Essential Thrombocythemia (ET).

In this interview, Dr. Fleischman discusses cutting-edge clinical trials, novel therapeutic approaches, and basic science concepts. For patients, caregivers, and healthcare professionals, this video provides a valuable look into the future of MPN care.

Watch the video to stay informed about how these advancements will shape MPN Research in 2025 and beyond.

For more MPN-focused content and resources, visit PV Reporter and MPN Cancer Connection.